Axial IntraOcular Lens position and posterior capsule opacification with a microincisional single-piece open-loop hydrophilic IntraOcular Lens: a randomised trial (XCelens Idea versus single-piece Acrysof IntraOcular Lens)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN88407981

Enrollment

Registered

2007-01-29

Start date

2006-11-28

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Interventions

Intraocular lens implant (XCelens Idea or Acrysof)

Eligibility

Inclusion criteria

Inclusion criteria: 1. Bilateral age-related cataract 2. Age 40 and older 3. Visual Acuity more than 0.05 4. Normal findings in the medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant 5. Written informed consent to surgery and participation in the study

Exclusion criteria

Exclusion criteria: Relevant other ophthalmic diseases (such as pseudoexfoliation, glaucoma, retinal degenerations, ocular trauma, etc.)

Design outcomes

Primary

Measure	Time frame
Posterior Capsule Opacification (PCO), measured with an image analysis system Automated QUantification of After-cataract (AQUA), scale zero to ten, from digital retroillumination photographs of the posterior capsule at two years.	—

Secondary

Measure	Time frame
1. Anterior chamber depth (mm) with ACMaster 2. Decentration (mm) 3. Refraction 4. Rhexis size (mm^2) 5. Slitlamp biomicroscopy (descriptive)	—

Countries

Austria, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026